Abstract

Background: Vaccination against influenza may decrease the risk of an acute cardiovascular event in the elderly. The purpose of this study was to test the hypothesis that influenza vaccination could reduce hospitalizations for heart failure (HF) in patients with chronic obstructive pulmonary disease (COPD). Methods: Using Taiwan National Health Insurance Research Dataset (NHIRD) 2000 to 2007, this cohort study comprised patients with a recorded diagnosis of COPD (n = 25,609) between January 1, 2000 and December 31, 2007. Each patient was followed up until the end of 2007. Cox proportional hazard regression analysis was used to evaluate the HF-free survival rates after adjusting for known confounding factors. Results: We found that patients with COPD but no history of a cardiovascular event had a lower risk of hospitalization for HF after receiving influenza vaccination. After adjusting for potential confounders, there was a possible decrease in HF admission for the vaccinated group [hazard ratio (HR), 0.44, 95% confidence interval (CI), 0.35-0.55]. When stratified in terms of the patients' ages, the adjusted HR for hospitalization due to HF was 0.36 (95% CI, 0.28-0.46) for vaccinated patients over 64 years of age; however, the adjusted HR for HF in patients under 55 years of age who had received vaccination was not significant. Conclusion: Our data show that there was a lower rate of hospitalization from HF in patients with COPD receiving influenza vaccination, but only in patients older than 65 years.

Original languageEnglish
Pages (from-to)65-68
Number of pages4
JournalJournal of Experimental and Clinical Medicine(Taiwan)
Volume5
Issue number2
DOIs
Publication statusPublished - Apr 2013

Fingerprint

Chronic Obstructive Pulmonary Disease
Human Influenza
Vaccination
Hospitalization
Heart Failure
Confidence Intervals
National Health Programs
Taiwan
Cohort Studies
Survival Rate
Regression Analysis
Research

Keywords

  • Adjusted hazard ratio
  • Cardiovascular disease
  • Chronic obstructive pulmonary disease
  • Cohort study
  • Taiwan National Health Insurance Research Dataset (NHIRD)

ASJC Scopus subject areas

  • Medicine(all)

Cite this

@article{9d93528af1824fd0b12f20dc14918c40,
title = "Influenza vaccination may lead to reduction of hospitalization for heart failure in elderly patients with chronic obstructive pulmonary disease",
abstract = "Background: Vaccination against influenza may decrease the risk of an acute cardiovascular event in the elderly. The purpose of this study was to test the hypothesis that influenza vaccination could reduce hospitalizations for heart failure (HF) in patients with chronic obstructive pulmonary disease (COPD). Methods: Using Taiwan National Health Insurance Research Dataset (NHIRD) 2000 to 2007, this cohort study comprised patients with a recorded diagnosis of COPD (n = 25,609) between January 1, 2000 and December 31, 2007. Each patient was followed up until the end of 2007. Cox proportional hazard regression analysis was used to evaluate the HF-free survival rates after adjusting for known confounding factors. Results: We found that patients with COPD but no history of a cardiovascular event had a lower risk of hospitalization for HF after receiving influenza vaccination. After adjusting for potential confounders, there was a possible decrease in HF admission for the vaccinated group [hazard ratio (HR), 0.44, 95{\%} confidence interval (CI), 0.35-0.55]. When stratified in terms of the patients' ages, the adjusted HR for hospitalization due to HF was 0.36 (95{\%} CI, 0.28-0.46) for vaccinated patients over 64 years of age; however, the adjusted HR for HF in patients under 55 years of age who had received vaccination was not significant. Conclusion: Our data show that there was a lower rate of hospitalization from HF in patients with COPD receiving influenza vaccination, but only in patients older than 65 years.",
keywords = "Adjusted hazard ratio, Cardiovascular disease, Chronic obstructive pulmonary disease, Cohort study, Taiwan National Health Insurance Research Dataset (NHIRD)",
author = "Chen, {Chang I.} and Li-Chin Sung and Miser, {James S.} and Fang, {Yu Ann} and Tsai, {Ching Quan} and Liu, {Ju Chi} and Li, {Yu Chuan}",
year = "2013",
month = "4",
doi = "10.1016/j.jecm.2013.02.002",
language = "English",
volume = "5",
pages = "65--68",
journal = "Journal of Experimental and Clinical Medicine",
issn = "1878-3317",
publisher = "Elsevier Taiwan LLC",
number = "2",

}

TY - JOUR

T1 - Influenza vaccination may lead to reduction of hospitalization for heart failure in elderly patients with chronic obstructive pulmonary disease

AU - Chen, Chang I.

AU - Sung, Li-Chin

AU - Miser, James S.

AU - Fang, Yu Ann

AU - Tsai, Ching Quan

AU - Liu, Ju Chi

AU - Li, Yu Chuan

PY - 2013/4

Y1 - 2013/4

N2 - Background: Vaccination against influenza may decrease the risk of an acute cardiovascular event in the elderly. The purpose of this study was to test the hypothesis that influenza vaccination could reduce hospitalizations for heart failure (HF) in patients with chronic obstructive pulmonary disease (COPD). Methods: Using Taiwan National Health Insurance Research Dataset (NHIRD) 2000 to 2007, this cohort study comprised patients with a recorded diagnosis of COPD (n = 25,609) between January 1, 2000 and December 31, 2007. Each patient was followed up until the end of 2007. Cox proportional hazard regression analysis was used to evaluate the HF-free survival rates after adjusting for known confounding factors. Results: We found that patients with COPD but no history of a cardiovascular event had a lower risk of hospitalization for HF after receiving influenza vaccination. After adjusting for potential confounders, there was a possible decrease in HF admission for the vaccinated group [hazard ratio (HR), 0.44, 95% confidence interval (CI), 0.35-0.55]. When stratified in terms of the patients' ages, the adjusted HR for hospitalization due to HF was 0.36 (95% CI, 0.28-0.46) for vaccinated patients over 64 years of age; however, the adjusted HR for HF in patients under 55 years of age who had received vaccination was not significant. Conclusion: Our data show that there was a lower rate of hospitalization from HF in patients with COPD receiving influenza vaccination, but only in patients older than 65 years.

AB - Background: Vaccination against influenza may decrease the risk of an acute cardiovascular event in the elderly. The purpose of this study was to test the hypothesis that influenza vaccination could reduce hospitalizations for heart failure (HF) in patients with chronic obstructive pulmonary disease (COPD). Methods: Using Taiwan National Health Insurance Research Dataset (NHIRD) 2000 to 2007, this cohort study comprised patients with a recorded diagnosis of COPD (n = 25,609) between January 1, 2000 and December 31, 2007. Each patient was followed up until the end of 2007. Cox proportional hazard regression analysis was used to evaluate the HF-free survival rates after adjusting for known confounding factors. Results: We found that patients with COPD but no history of a cardiovascular event had a lower risk of hospitalization for HF after receiving influenza vaccination. After adjusting for potential confounders, there was a possible decrease in HF admission for the vaccinated group [hazard ratio (HR), 0.44, 95% confidence interval (CI), 0.35-0.55]. When stratified in terms of the patients' ages, the adjusted HR for hospitalization due to HF was 0.36 (95% CI, 0.28-0.46) for vaccinated patients over 64 years of age; however, the adjusted HR for HF in patients under 55 years of age who had received vaccination was not significant. Conclusion: Our data show that there was a lower rate of hospitalization from HF in patients with COPD receiving influenza vaccination, but only in patients older than 65 years.

KW - Adjusted hazard ratio

KW - Cardiovascular disease

KW - Chronic obstructive pulmonary disease

KW - Cohort study

KW - Taiwan National Health Insurance Research Dataset (NHIRD)

UR - http://www.scopus.com/inward/record.url?scp=84876141604&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84876141604&partnerID=8YFLogxK

U2 - 10.1016/j.jecm.2013.02.002

DO - 10.1016/j.jecm.2013.02.002

M3 - Article

VL - 5

SP - 65

EP - 68

JO - Journal of Experimental and Clinical Medicine

JF - Journal of Experimental and Clinical Medicine

SN - 1878-3317

IS - 2

ER -